Couverture de Ozempic for Heart Disease — The New Research

Ozempic for Heart Disease — The New Research

Ozempic for Heart Disease — The New Research

De : Inception Point Ai
Écouter gratuitement

À propos de ce contenu audio

 Semaglutide just earned FDA approval for heart disease—not just weight loss. Host Julia Cartwright unpacks the landmark trial data, the mysterious biological mechanisms protecting the heart, and the real-world questions of who gets access to this breakthrough cardiovascular treatment.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai
Épisodes
  • Ozempic for Heart Disease — Uncover the breakthrough science with Julia Cartwright

    Ozempic for Heart Disease — Uncover the breakthrough science with Julia Cartwright
    Apr 7 2026
    Join host Julia Cartwright as she explores how Ozempic, widely known for weight loss, is emerging as a groundbreaking treatment for heart disease. Through compelling insights into major clinical trials, Julia reveals who benefits most and tackles the critical access issues surrounding this potential cardiac game-changer.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Afficher plus Afficher moins
    1 min
Aucun commentaire pour le moment